MAPT and Alzheimer disease: Moreover, type 1 IFN signaling, which is known to be stimulated by tau and implicated in exacerbating AD pathology and cognitive deficits9, was suppressed in Hvcn1−/−+AAV-hTAU mice (Supplementary Fig. 3 d).